Search results
Results from the WOW.Com Content Network
The most severe cases may result in poor adherence to medications, exacerbation of psychiatric symptoms, and, because of this, aggression, violence, and/or suicidal thoughts. [2] Akathisia is also associated with threatening behaviour and physical aggression in mentally disordered patients. [8]
In more severe cases, the motions may become harmful to the individual, and may involve things such as ripping, tearing, or chewing at the skin around one's fingernails, lips, or other body parts to the point of bleeding. Psychomotor agitation is typically found in various mental disorders, especially in psychotic and mood disorders.
Restless legs syndrome (RLS), (also known as Willis–Ekbom disease (WED), is a neurological disorder, usually chronic, that causes an overwhelming urge to move one's legs. [2] [10] There is often an unpleasant feeling in the legs that improves temporarily by moving them. [2] This feeling is often described as aching, tingling, or crawling in ...
The symptoms can be acute (short-term) or chronic (long-term). They include movement dysfunction such as dystonia (continuous spasms and muscle contractions), akathisia (may manifest as motor restlessness), [ 1 ] parkinsonism characteristic symptoms such as rigidity , bradykinesia (slowness of movement), tremor , and tardive dyskinesia ...
Dementia is a devastating condition that impacts up to 10 percent of older adults. And while there's no cure, getting diagnosed early can help patients get on a treatment plan and families prepare ...
Debrina Kawam, the NYC subway passenger who was burned to death, was known to her classmates as “Debbie” or “Deb,” and graduated from Passaic Valley Regional School in Little Falls, New ...
Hyperkinesia is a state of excessive restlessness which is featured in a large variety of disorders that affect the ability to control motor movement, such as Huntington's disease. It is the opposite of hypokinesia , which refers to decreased bodily movement, as commonly manifested in Parkinson's disease .
Mark Cuban, CEO of Cost Plus Drugs, told BI that AI's impact on a company's workforce will be determined by how well the technology is implemented.